Akebia Therapeutics
AKBA
#8810
Rank
NZ$0.42 B
Marketcap
NZ$1.53
Share price
-4.41%
Change (1 day)
-67.98%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: NZ$0.42 Billion

As of September 2026 Akebia Therapeutics has a market cap of NZ$0.42 Billion. This makes Akebia Therapeutics the world's 8810th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.42 B-44.36%
2025NZ$0.76 B0.82%
2024NZ$0.75 B104.23%
2023NZ$0.36 B120.95%
2022NZ$0.16 B-71.12%
2021NZ$0.57 B3.21%
2020NZ$0.56 B-50.88%
2019NZ$1.14 B18.49%
2018NZ$0.96 B-2.63%
2017NZ$0.98 B71.84%
2016NZ$0.57 B-0.5%
2015NZ$0.57 B91.27%
2014NZ$0.30 B

End of Day market cap according to different sources

On Sep 16th, 2026 the market cap of Akebia Therapeutics was reported to be:

NZ$0.44 Billion
by Nasdaq info icon info icon
NZ$0.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.124 T 265,597.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$465.18 B 109,827.88%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
NZ$357.56 B 84,395.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$4.12 B 874.27%๐Ÿ‡บ๐Ÿ‡ธ USA